5AM Venture Management, LLC 13F holdings, Q2 2025
Holdings as of June 30, 2025 · filings on SEC EDGAR · latest filing →
5AM Venture Management, LLC disclosed 29 US equity positions worth $260.1m in its Q2 2025 13F filing. The largest position was SKYE at 15.9% of the reported book, followed by TRDA and DNTH. Against the Q1 2025 filing, it opened 0 new positions, added to 0 and reduced 3 among the top 29 holdings.
What did 5AM Venture Management, LLC own in Q2 2025? Top 29 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q1 2025 |
|---|---|---|---|---|---|---|---|
| 1 | SKYE SKYE BIOSCIENCE INC | 15.9% | $41.4m | 9,913,168 | 0% | held | |
| 2 | TRDA ENTRADA THERAPEUTICS INC | 11.1% | $29.0m | 4,308,379 | -2% | reduced | |
| 3 | DNTH DIANTHUS THERAPEUTICS INC | Healthcare | 7.1% | $18.3m | 984,725 | -4% | reduced |
| 4 | ELVN ENLIVEN THERAPEUTICS INC | Healthcare | 6.0% | $15.5m | 772,477 | -42% | reduced |
| 5 | PHVS PHARVARIS N V | 5.4% | $14.0m | 797,600 | 0% | held | |
| 6 | MLTX MOONLAKE IMMUNOTHERAPEUTICS | Healthcare | 5.1% | $13.3m | 282,313 | 0% | held |
| 7 | CNTA CENTESSA PHARMACEUTICALS PLC | 4.2% | $10.9m | 830,945 | 0% | held | |
| 8 | VOR VOR BIOPHARMA INC | 4.0% | $10.3m | 6,361,723 | 0% | held | |
| 9 | VRDN VIRIDIAN THERAPEUTICS INC | Healthcare | 4.0% | $10.3m | 736,595 | 0% | held |
| 10 | TECX TECTONIC THERAPEUTIC INC | Healthcare | 3.9% | $10.2m | 511,660 | 0% | held |
| 11 | CLDX CELLDEX THERAPEUTICS INC NEW | Healthcare | 3.9% | $10.1m | 497,270 | 0% | held |
| 12 | EYPT EYEPOINT PHARMACEUTICALS INC | Healthcare | 3.8% | $9.9m | 1,050,000 | 0% | held |
| 13 | TYRA TYRA BIOSCIENCES INC | Healthcare | 3.5% | $9.0m | 939,298 | 0% | held |
| 14 | PRAX PRAXIS PRECISION MEDICINES I | Healthcare | 2.7% | $7.1m | 170,000 | 0% | held |
| 15 | GHRS GH RESEARCH PLC | 2.7% | $7.0m | 572,665 | 0% | held | |
| 16 | ERAS ERASCA INC | Healthcare | 2.6% | $6.9m | 5,405,404 | 0% | held |
| 17 | BHVN BIOHAVEN LTD | Healthcare | 2.6% | $6.8m | 478,972 | 0% | held |
| 18 | VKTX VIKING THERAPEUTICS INC | Healthcare | 1.9% | $5.0m | 189,593 | 0% | held |
| 19 | SCPH SCPHARMACEUTICALS INC | 1.8% | $4.6m | 1,200,647 | 0% | held | |
| 20 | CAMP CAMP4 THERAPEUTICS CORP | 1.6% | $4.2m | 2,927,915 | 0% | held | |
| 21 | ARTV ARTIVA BIOTHERAPEUTICS INC | 1.4% | $3.6m | 2,353,304 | 0% | held | |
| 22 | SRZN SURROZEN INC | 1.1% | $2.8m | 310,000 | 0% | held | |
| 23 | SLN SILENCE THERAPEUTICS PLC | 1.1% | $2.8m | 476,200 | 0% | held | |
| 24 | TARA PROTARA THERAPEUTICS INC | 0.9% | $2.4m | 800,000 | 0% | held | |
| 25 | ALEC ALECTOR INC | Healthcare | 0.5% | $1.4m | 995,841 | 0% | held |
| 26 | RLYB RALLYBIO CORP | 0.5% | $1.2m | 3,630,724 | 0% | held | |
| 27 | AVU0 ADVERUM BIOTECHNOLOGIES INC | 0.4% | $1.2m | 541,666 | 0% | held | |
| 28 | ZNTL ZENTALIS PHARMACEUTICALS INC | Healthcare | 0.2% | $568.4k | 490,000 | 0% | held |
| 29 | MERSANA THERAPEUTICS INC | 0.1% | $386.3k | 1,305,000 | 0% | held |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.